Literatur
Kobayashi T et al (2012) Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet 379(9826):1613–1620
Kim BY et al (2016) Non-responders to intravenous immunoglobulin and coronary artery dilatation in Kawasaki disease: predictive parameters in korean children. Korean Circ J 46(4):542–549
Tang Y et al (2016) Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an East China population. Clin Rheumatol 35(11):2771–2776
Davies S et al (2015) Predicting IVIG resistance in UK Kawasaki disease. Arch Dis Child 100(4):366–368
Sleeper LA et al (2011) Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr 158(5):831–835.e3
Kobayashi T et al (2006) Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113(22):2606–2612
Chen S et al (2013) Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis. Heart 99(2):76–82
Chen S et al (2016) Coronary artery complication in Kawasaki disease and the importance of early intervention : A systematic review and meta-analysis. JAMA Pediatr. doi:10.1001/jamapediatrics.2016.2055
Newburger JW et al (2007) Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med 356(7):663–675
Okada Y et al (2003) Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr 143(3):363–367
Sundel RP et al (2003) Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Pediatr 142(6):611–616
Ogata S et al (2012) Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial. Pediatrics 129(1): p:e17–23
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A. Jakob und M. Hufnagel geben an, dass kein Interessenkonflikt besteht.
Additional information
Redaktion
R. Berner, Dresden
B. Koletzko, München
W. Sperl, Salzburg
Rights and permissions
About this article
Cite this article
Jakob, A., Hufnagel, M. Steroidtherapie und Kawasaki-Syndrom. Monatsschr Kinderheilkd 165, 184–185 (2017). https://doi.org/10.1007/s00112-016-0218-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00112-016-0218-4